Cargando…
IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors
Chromosome rearrangements resulting in pathogenetically important gene fusions are a common feature of many cancers. They are often potent oncogenic drivers and have key functions in central cellular processes and pathways and encode transcription factors, transcriptional co-regulators, growth facto...
Autores principales: | Andersson, Mattias K., Åman, Pierre, Stenman, Göran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721700/ https://www.ncbi.nlm.nih.gov/pubmed/31426421 http://dx.doi.org/10.3390/cells8080913 |
Ejemplares similares
-
Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast
por: Kovács, Anikó, et al.
Publicado: (2017) -
ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
por: Andersson, Mattias K., et al.
Publicado: (2020) -
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study
por: Persson, Marta, et al.
Publicado: (2022) -
Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma
por: Humtsoe, Joseph O., et al.
Publicado: (2022) -
A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets
por: Gao, Ruli, et al.
Publicado: (2014)